Utah Lawmakers Unanimously Approve Bill To Allow Psilocybin And MDMA Treatment At Hospitals, Sending It To The Governor
Top Federal Drug Agency Cites Marijuana And Psychedelics Research Efforts To Justify Congressional Funding
Virginia Lawmakers Don’t Expect Governor To Sign Marijuana Sales Bill
Maryland House Approves Bill To Create Psychedelics Task Force To Study Regulated Therapeutic Access
Massachusetts Governor To Pardon Hundreds Of Thousands With Marijuana Convictions
Psychedelic Use Linked To ‘Lower Rates Of Psychotic Symptoms’ In Adolescents, Study Published By American Medical Association Finds
Marijuana Can Help Increase Orgasm Frequency And Satisfaction For Women, Study Finds
Teen Use Of Delta-8 THC Is Higher In States Without Legal Marijuana, New Study Published By American Medical Association Finds
New USDA Hemp ‘Roadmap’ Highlights Research Needs And Proposes Public-Private Consortium To Streamline Studies
CBD May Ease Menstrual-Related Symptoms Like Irritability And Stress, Study Finds
Marijuana Rolling Paper Company Seeks Content Creator To ‘Get Paid To Smoke Weed’ For $70,420 Salary
Nevada’s First Marijuana Consumption Lounge Officially Opens, With Top Lawmaker Hitting A Joint At 4:20
Rapper Killer Mike Suggests Giving Black People Control Over Marijuana Industry As A Form Of Reparations
Brooklyn Nets And New York Liberty Become First NBA And WNBA Teams To Partner With CBD Company
UFC Warns Fighters To Stop Using Marijuana ‘Immediately’ So They Aren’t Punished Under California Athletics Rules
Massachusetts Marijuana Sales Pass $7 Billion Mark As Prices Hit Record Low
U.S. Company Offers Free Psychedelics Training Services To Ukraine Health Professionals To Treat Trauma From War With Russia
New Mexico Officials Celebrate Marijuana Milestone As Sales Cross $1 Billion Mark Since Recreational Market Launched
Missouri’s Marijuana Market Tallied More Than $1.4 Billion During First Full Year Of Adult-Use Sales
Missouri Marijuana Company Argues That Workers Are Not Allowed To Unionize Due To Federal Law
Massachusetts Governor To Pardon Hundreds Of Thousands With Marijuana Convictions
Hawaii Senate Panel Guts House-Passed Marijuana Expungements Bill, Limiting It To A Single-County Pilot Program
‘Rats Are Eating Our Marijuana,’ New Orleans Police Superintendent Tells City Council, Adding That ‘They’re All High’
Arizona House Panel Advances Bill To Legalize Psilocybin Service Centers That Has Already Passed The Full Senate
New Hampshire GOP Governor Reaffirms He’d Sign Marijuana Legalization Bill With State-Run Model Despite Personal Reservations
Feds pressed on cannabis research delays (Newsletter: March 13, 2024)
DEA cannabis rescheduling turmoil (Newsletter: March 12, 2024)
Virginia governor vetoes cannabis bill (Newsletter: March 11, 2024)
Biden touts cannabis moves in State of the Union (Newsletter: March 8, 2024)
Cannabis banking on tap for passage by Nov, Schumer says (Newsletter: March 7, 2024)
Published
on
By
The Connecticut House of Representatives has approved a bill to decriminalize possession of psilocybin mushrooms, sending it to the Senate.
The legislation—which was introduced by the Judiciary Committee and cleared that panel in March—passed the House in an 86-64 vote on Wednesday.
Under the measure, possession of up to half an ounce of psilocybin would be a civil infraction, punishable by a $150 fine. Subsequent violations could carry fines ranging from $200 to $500.
People who are found guilty three times under the policy would be referred to a drug education program.
As it stands, simple possession of psilocybin is considered a Class A misdemeanor in Connecticut, with penalties of up to a year in jail and a maximum $2,000 fine.
Watch the Connecticut House discuss the psychedelics legislation, starting at 4:04:10 into the video below:
Researchers have found that psilocybin is a “promising treatment for some behavioral health conditions, including substance use, depression and palliative care for end of life anxiety and depression,” Rep. Steven Stafstrom (D), co-chair of the legislature’s Joint Judiciary Committee, said on the floor on Wednesday. However, “research to date on psilocybin continues to lag behind.”
As the federal Food and Drug Administration (FDA) investigates authorizing psilocybin as a therapeutic, the Connecticut bill represents an “interim” reform to “decriminalize small amounts of this so that we are not continuing to perpetrate the war on drugs and to incarcerate individuals for possession of very small amounts of this substance when we know it contains such medical uses,” Stafstrom said.
The bill, HB 6734, is now moving to the Senate for consideration before potentially being sent to the governor.
Connecticut has become something of a hub for psychedelics policy reform.
Gov. Ned Lamont (D) signed a large-scale budget bill last year that includes provisions to set the state up to provide certain patients with access to psychedelic-assisted treatment using substances like MDMA and psilocybin.
A state lawmaker also introduced separate legislation this session that would appropriate a currently unspecified amount of state funds to the Department of Mental Health and Addiction Services for the current fiscal year to establish a “psychedelic-assisted therapy pilot program.”
—
Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
Lawmakers in states across the country have been working to enact psychedelics reform this session.
For example, Arizona lawmakers approved budget legislation on Wednesday that includes provisions to fund research into the medical potential of psilocybin mushrooms for a variety of conditions.
The governor of Washington State signed a bill on Tuesday to promote research into psilocybin and create a pilot program to provide therapeutic access to the psychedelic for mental health treatment.
Vermont lawmakers held a committee hearing last week where members discussed legislation to legalize psilocybin and take first steps toward providing regulated access to the psychedelic.
A California bill to legalize the possession of certain psychedelics and facilitated use of the substances is heading to the Senate floor under an accelerated process that is allowing it to skip further committee consideration.
The Minnesota House recently passed an omnibus health bill that contains provisions to create a psychedelics task force meant to prepare the state for possible legalization.
Last month, a Republican North Carolina lawmaker and a bipartisan group of cosponsors filed a bill to create a $5 million grant program to support research into the therapeutic potential of psilocybin and MDMA and to create a Breakthrough Therapies Research Advisory Board to oversee the effort.
A Nevada Senate committee approved a revised bill last month that would create a new working group to study psychedelics and develop a plan to allow regulated access for therapeutic purposes.
The Hawaii Senate approved a bill last month to create an advisory council to look into possible regulations to provide access to federal “breakthrough therapies” like psilocybin and MDMA.
Oregon regulators recently approved the nation’s first license for a psilocybin service center where people will be able to use the psychedelic in a supervised and facilitated environment.
Meanwhile, National Institute on Drug Abuse (NIDA) Director Nora Volkow told senators last week that there is emerging evidence that psychedelics carry “significant potential” as therapeutic treatments for certain mental health conditions, and it’s a topic of “great interest” for researchers.
An analysis published in an American Medical Association journal last year concluded that a majority of states will legalize psychedelics by 2037, based on statistical modeling of policy trends.
A national poll published in March found that a majority of U.S. voters support legal access to psychedelics therapy and back federally decriminalizing substances like psilocybin and MDMA.
Watch Live: U.S. Senate Committee Holds Marijuana Banking Hearing
Photo courtesy of Wikimedia/Workman.
Schumer, Booker And Wyden Renew Call For Marijuana Expungements To Be Added To Banking Bill Following Committee Hearing
U.S. Senate Committee Holds Marijuana Banking Hearing
Kyle Jaeger is Marijuana Moment’s Sacramento-based managing editor. His work has also appeared in High Times, VICE and attn.
Utah Lawmakers Unanimously Approve Bill To Allow Psilocybin And MDMA Treatment At Hospitals, Sending It To The Governor
Top Federal Drug Agency Cites Marijuana And Psychedelics Research Efforts To Justify Congressional Funding
Virginia Lawmakers Don’t Expect Governor To Sign Marijuana Sales Bill
Maryland House Approves Bill To Create Psychedelics Task Force To Study Regulated Therapeutic Access
Psychedelic Use Linked To ‘Lower Rates Of Psychotic Symptoms’ In Adolescents, Study Published By American Medical Association Finds
Massachusetts Governor To Pardon Hundreds Of Thousands With Marijuana Convictions
All the cannabis news you need, all in one place. Copyright © 2017-2024 Marijuana Moment LLC ® and Tom Angell
Connecticut House Approves Psilocybin Decriminalization Bill, Sending It To Senate – Marijuana Moment
